Coral Laboratories Intrinsic Value
CORALAB Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1069.20 | ₹855.36 - ₹1283.04 | +140.7% | EPS: ₹48.60, Sector P/E: 22x |
| Book Value Method | asset | ₹1005.00 | ₹904.50 - ₹1105.50 | +126.2% | Book Value/Share: ₹502.50, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹495.00 | ₹445.50 - ₹544.50 | +11.4% | Revenue/Share: ₹247.50, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹625.00 | ₹562.50 - ₹687.50 | +40.7% | EBITDA: ₹25.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹441.46 | ₹353.17 - ₹529.75 | -0.6% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹688.35 | ₹619.51 - ₹757.19 | +54.9% | EPS Growth: 17.7%, Fair P/E: 14.2x |
| Growth Adjusted P/E | growth | ₹748.94 | ₹674.05 - ₹823.83 | +68.6% | Revenue Growth: 5.5%, Adj P/E: 15.4x |
| ROE Based Valuation | profitability | ₹425.00 | ₹382.50 - ₹467.50 | -4.3% | ROE: 8.5%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹741.27 | ₹667.14 - ₹815.40 | +66.9% | EPS: ₹48.60, BVPS: ₹502.50 |
Want to compare with current market value? Check CORALAB share price latest .
Valuation Comparison Chart
CORALAB Intrinsic Value Analysis
What is the intrinsic value of CORALAB?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Coral Laboratories (CORALAB) is ₹688.35 (median value). With the current market price of ₹444.25, this represents a +54.9% variance from our estimated fair value.
The valuation range spans from ₹425.00 to ₹1069.20, indicating ₹425.00 - ₹1069.20.
Is CORALAB undervalued or overvalued?
Based on our multi-method analysis, Coral Laboratories (CORALAB) appears to be trading below calculated value by approximately 54.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 59.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.14 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 8.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 18.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.43x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Coral Laboratories
Additional stock information and data for CORALAB
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹13 Cr | ₹12 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹6 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |